Ascletis Pharma (China) Co., Limited clinical trials

A country office of Ascletis Pharma Inc.

The registry lists 12 studies whose lead sponsor is Ascletis Pharma (China) Co., Limited. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Status

Completed: 7
Recruiting: 5

Phase

Phase 1: 8
Phase 2: 3
Phase 3: 2

Where

United States: 11
United Kingdom: 2
Czechia: 2
Greece: 2
Poland: 2
Germany: 2

Registry sponsor names on this page

Ascletis Pharma (China) Co., Limited12 studies

Something wrong with this grouping? Tell us on the Ascletis Pharma Inc. page.

Studies

Recruiting first, then most recently updated. Showing 12 of 12. All Ascletis Pharma Inc. studies →

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or OverweightRecruitingNCT07893093Phase 1
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or OverweightRecruitingNCT07893106Phase 1
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or OverweightRecruitingNCT07842640Phase 1
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesRecruitingNCT07743463Phase 3
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesRecruitingNCT07743450Phase 3
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque PsoriasisCompletedNCT07024602Phase 1
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes MellitusCompletedNCT07321678Phase 2
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With ObesityCompletedNCT06679959Phase 1/2
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With SemaglutideCompletedNCT06972992Phase 1
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related ComorbiditiesCompletedNCT07002905Phase 2
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With ObesityCompletedNCT06680440Phase 1
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese SubjectsCompletedNCT06427590Phase 1
Sponsor listed in the registry: Ascletis Pharma (China) Co., Limited